Lori Lawley

Directeur Financier/CFO chez LUMOS PHARMA, INC.

42 ans

Health Technology

Commercial Services

Consumer Services

Profil

Lori Lawley is currently Chief Financial Officer & Secretary at Lumos Pharma, Inc. since 2020.
Former positions include Vice President-Finance & Controller at NewLink Genetics Corp.
from 2018 to 2020 and Senior Manager at Ernst & Young LLP from 2014 to 2015.
Education includes undergraduate and graduate degrees from McCombs School of Business.

Postes actifs de Lori Lawley

Sociétés	Poste	Début
LUMOS PHARMA, INC.	Directeur Financier/CFO	04/07/2021

Tous les postes actifs de Lori Lawley

Anciens postes connus de Lori Lawley

Sociétés	Poste	Fin
LUMOS PHARMA, INC.	Comptroller/Controller/Auditor	01/03/2020
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Corporate Officer/Principal	01/04/2015

Voir l'expérience en détail de Lori Lawley

Formation de Lori Lawley

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Lori Lawley

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Ernst & Young LLP Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services	Commercial Services
NewLink Genetics Corp. NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer	Health Technology
McCombs School of Business McCombs School of Business Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Lumos Pharma, Inc. Lumos Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and markets therapeutics for rare diseases	Health Technology